Kenneth V. LAWSON

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Inhibitors of adenosine 5′-nucleotidase
- Patent number 12,168,023
- Issue date Dec 17, 2024
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for preparing tetralin compounds
- Patent number 12,145,901
- Issue date Nov 19, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 12,103,907
- Issue date Oct 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of HIF-2α and methods of use thereof
- Patent number 12,071,411
- Issue date Aug 27, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD73 inhibitors
- Patent number 11,931,343
- Issue date Mar 19, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid forms of a CD73 inhibitor and the use thereof
- Patent number 11,819,512
- Issue date Nov 21, 2023
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh Jeffrey
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha
- Patent number 11,787,762
- Issue date Oct 17, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of 5′-nucleotidase, ecto and the use thereof
- Patent number 11,667,662
- Issue date Jun 6, 2023
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Oral formulations of CD73 compounds
- Patent number 11,633,416
- Issue date Apr 25, 2023
- ARCUS BIOSCIENCES, INC.
- Kenneth Victor Lawson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α
- Patent number 11,407,712
- Issue date Aug 9, 2022
- ARCUS BIOSCIENCES, INC.
- Joel Worley Beatty
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of CD73-mediated immunosuppression
- Patent number 11,267,845
- Issue date Mar 8, 2022
- ARCUS BIOSCIENCES, INC.
- Jaroslaw Kalisiak
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of adenosine 5′-nucleotidase
- Patent number 11,058,704
- Issue date Jul 13, 2021
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of 5′-nucleotidase, ecto and the use thereof
- Patent number 11,001,603
- Issue date May 11, 2021
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of 5′-nucleotidase, ecto and the use thereof
- Patent number 10,981,944
- Issue date Apr 20, 2021
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modulators of 5′-nucleotidase, ecto and the use thereof
- Patent number 10,239,912
- Issue date Mar 26, 2019
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul Debien
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CBL-B INHIBITORS AND METHODS OF USE THEREOF
- Publication number 20250011318
- Publication date Jan 9, 2025
- ARCUS BIOSCIENCES, INC.
- Srikanth Kumar Gangam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Cbl-b Inhibitors and Methods of Use Thereof
- Publication number 20240425497
- Publication date Dec 26, 2024
- ARCUS BIOSCIENCES, INC.
- Srikanth Kumar Gangam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
- Publication number 20240352057
- Publication date Oct 24, 2024
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
- Publication number 20240285665
- Publication date Aug 29, 2024
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20240254079
- Publication date Aug 1, 2024
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF
- Publication number 20230159466
- Publication date May 25, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS
- Publication number 20230024302
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF HIF-2ALPHA
- Publication number 20230024438
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20230021476
- Publication date Jan 26, 2023
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF
- Publication number 20220062313
- Publication date Mar 3, 2022
- ARCUS BIOSCIENCES, INC.
- Jenna Leigh JEFFREY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
- Publication number 20210371449
- Publication date Dec 2, 2021
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD73 INHIBITORS
- Publication number 20210346353
- Publication date Nov 11, 2021
- ARCUS BIOSCIENCES, INC.
- Joel BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA
- Publication number 20210317079
- Publication date Oct 14, 2021
- ARCUS BIOSCIENCES, INC.
- Joel Worley BEATTY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
- Publication number 20210002322
- Publication date Jan 7, 2021
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS
- Publication number 20200405629
- Publication date Dec 31, 2020
- ARCUS BIOSCIENCES, INC.
- Juan Carlos JAEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE
- Publication number 20200222441
- Publication date Jul 16, 2020
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF CD73-MEDIATED IMMUNOSUPPRESSION
- Publication number 20200062797
- Publication date Feb 27, 2020
- ARCUS BIOSCIENCES, INC.
- Jaroslaw KALISIAK
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
- Publication number 20190309010
- Publication date Oct 10, 2019
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF
- Publication number 20170267710
- Publication date Sep 21, 2017
- ARCUS BIOSCIENCES, INC.
- Laurent Pierre Paul DEBIEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Kenneth V. LAWSON

Person

Patents Grantslast 30 patents

Inhibitors of adenosine 5′-nucleotidase

Process for preparing tetralin compounds

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Inhibitors of HIF-2α and methods of use thereof

CD73 inhibitors

Solid forms of a CD73 inhibitor and the use thereof

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha

Modulators of 5′-nucleotidase, ecto and the use thereof

Oral formulations of CD73 compounds

Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2α

Inhibitors of CD73-mediated immunosuppression

Inhibitors of adenosine 5′-nucleotidase

Modulators of 5′-nucleotidase, ecto and the use thereof

Modulators of 5′-nucleotidase, ecto and the use thereof

Modulators of 5′-nucleotidase, ecto and the use thereof

Patents Applicationslast 30 patents

CBL-B INHIBITORS AND METHODS OF USE THEREOF

Cbl-b Inhibitors and Methods of Use Thereof

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

INHIBITORS OF HIF-2ALPHA AND METHODS OF USE THEREOF

2,3,5-TRISUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE COMPOUNDS

INHIBITORS OF HIF-2ALPHA

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

SOLID FORMS OF A CD73 INHIBITOR AND THE USE THEREOF

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

CD73 INHIBITORS

TETRALIN AND TETRAHYDROQUINOLINE COMPOUNDS AS INHIBITORS OF HIF-2ALPHA

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS

INHIBITORS OF ADENOSINE 5'-NUCLEOTIDASE

INHIBITORS OF CD73-MEDIATED IMMUNOSUPPRESSION

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF

MODULATORS OF 5'-NUCLEOTIDASE, ECTO AND THE USE THEREOF